NEW YORK (Reuters) -U.S. Senator Elizabeth Warren has asked antitrust regulators to scrutinize a $16.5 billion deal in which ...

Sen. Elizabeth Warren urges FTC to scrutinize Novo Nordisk's $16.5 billion acquisition of Catalent over concerns of increased ...

The "Nucleic Acid Therapeutics CDMO Market Size, Share & Trends Analysis, 2024-2030" report has been added to ...

Concerns are rising as Novo Nordisk's $16.5 billion bid to acquire Catalent faces scrutiny from the FTC. Critics argue the ...

As Novo Holdings hopes to close its $16.5 billion acquisition of CDMO Catalent by the end of the year, the deal is facing a fresh round of lawmaker scrutiny. | In a letter to the chair of the U.S.

Two former Pfizer executives said they will not be involved with activist investor Starboard Value, which reportedly wants ...

Senate Democrat Elizabeth Warren urges the Federal Trade Commission to closely scrutinize a proposed merger between Novo Nordisk and contract development and manufacturing organization Catalent, ...

Tesla on Thursday said it would give 500 of its temporary workers at a German gigafactory near Berlin permanent jobs from Nov ...

Chinese carmaker Chery has started assembling cars in Russia for sale in the country at three factories vacated by Western ...

The latest health news includes Illumina's launch of affordable gene sequencers, Pfizer's promising cancer drug trials, CVS ...

Ryan Specialty (NYSE:RYAN – Get Free Report) had its price objective lifted by Wells Fargo & Company from $63.00 to $70.00 in ...

Viridien (OTCMKTS:CGGYY – Get Free Report) was the target of a significant growth in short interest during the month of September. As of September 30th, there was short interest totalling 1,400 shares ...